The company Power3 Medical Products, USA, has developed a test for the identification of Alzheimer's disease at an early stage of the analysis of blood, reports BBC News.
Suffers from Alzheimer's disease about 2-5% of people over 65 years and up to 20% of people over 85 years. It destroys the conscience, is absurd and beyond death. Now Alzheimer's disease, and other neurodegenerative disease, identified only when symptoms become pronounced.
The test NuroPro defines Alzheimer's disease, and Parkinson's disease and amyotrophic lateral sclerosis (Gehrig's disease) on the levels of 59 biomarkers - blood proteins. Clinical trials that have already brought together 180 people, showed the success of the test in 70% of cases.
Last summer the company intends to issue a test of free sale in Greece, by the end of the year - in the United States.
While Alzheimer's disease is considered incurable, but scientists have announced razgadke mechanism for its development as well as taking a drug that can remove the symptoms of the disease at an early stage in 10 minutes.